Facial Plast Surg 2003; 19(1): 113-130
DOI: 10.1055/s-2003-39131
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Management of Adult Facial Vascular Anomalies

David W. Low
  • Division of Plastic Surgery, Edwin and Fannie Gray Hall Center for Human Appearance, University of Pennsylvania School of Medicine, Philadelphia, PA
Further Information

Publication History

Publication Date:
09 May 2003 (online)

ABSTRACT

Vascular anomalies are best classified by biologic behavior-active hemangiomas, and inactive vascular malformations. Hemangioma growth is restricted to infancy, but residual deformity may persist to adult life in the form of redundant skin, bulky fibrofatty tissue, and ectatic cutaneous vessels. Treatment largely consists of scar revision and laser photocoagulation of residual vascular pigmentation. Vascular malformations are present throughout life and can cause increasing facial distortion and disfigurement as capillaries, veins, lymphatics, and/or arteries further dilate and the facial features hypertrophy. A variety of treatment options include laser photocoagulation, sclerotherapy, embolization, and direct surgical excision, and often a combination of techniques yields improved results. In many cases, however, therapy is only palliative, and patients should be advised of the limitations of each treatment option to avoid unrealistic expectations and disappointing results.

REFERENCES

  • 1 Mulliken J B, Rogers G F, Marler J J. Circular excision of hemangioma and purse-string closure: the smallest possible scar.  Plast Reconstr Surg . 2002;  109(5) 1544-1554
  • 2 Zide B M, Glat P M, Stile F L, Longaker M T. Vascular lip enlargement: hemangiomas-tenets of therapy.  Plast Reconstr Surg . 1997;  100(7) 1664-1673
  • 3 Zide B M, Glat P M, Stile F L, Longaker M T. Vascular lip enlargement: port-wine macrochelia-tenets of therapy based on normative values.  Plast Reconstr Surg . 1997;  100(7) 1674-1681
  • 4 Derby L D, Low D W. Laser treatment of venous vascular malformations.  Ann Plast Surg . 1997;  38(4) 371-378
  • 5 Pappas Jr C D, Persky M S, Berenstein A. Evaluation and treatment of head and neck venous vascular malformations.  Ear Nose Throat J . 1998;  77(11) 914-922
  • 6 Ogita S. The role of OK-432 in the treatment of lymphangiomas: http://www.asahi-net.or.jp/~VF6S-OGT/ok-432role. html, 2002
  • 7 Padwa B L, Hayward P G, Ferraro N F, Mulliken J B. Cervicofacial lymphatic malformation: clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy.  Plast Reconstr Surg . 1995;  95(6) 951-960
  • 8 Bradley J P, Zide B M, Berenstein A, Longaker M T. Large arteriovenous malformations of the face: aesthetic results with recurrence control.  Plast Reconstr Surg . 1999;  103(2) 351-361
  • 9 Kirschner R E, Low D W. Treatment of pyogenic granulomas by shave excision and photocoagulation.  Plast Reconstr Surg . 1999;  104(5) 1346-1349
  • 10 The Proteus Foundation. What is Proteus syndrome? http://www.proteus-syndrome.org/html/about.html. 2002
    >